Setpointmedical
1 known investors
SetPoint Medical develops an implantable wireless device that stimulates the vagus nerve to reduce inflammation and treat rheumatoid arthritis through a neuroimmune modulation approach. The device is FDA-approved for adults with moderately to severely active rheumatoid arthritis who have inadequate response to biologics or targeted synthetic drugs.
BiotechHealthtechMedical Devices